Cargando…
The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer
BACKGROUND: The chemokine CXCL12 and its cognate receptor, CXCR4, have been implicated in numerous tumour types where expression promotes tumour growth, angiogenesis, metastasis and suppresses tumour immunity. METHODS: Using a tissue microarray of 289 primary ovarian cancers coupled to a comprehensi...
Autores principales: | Popple, A, Durrant, L G, Spendlove, I, Rolland, P, Scott, I V, Deen, S, Ramage, J M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314783/ https://www.ncbi.nlm.nih.gov/pubmed/22415233 http://dx.doi.org/10.1038/bjc.2012.49 |
Ejemplares similares
-
Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity
por: Gooden, M J M, et al.
Publicado: (2014) -
Expression of the chemokine CXCL14 in the tumour stroma is an independent marker of survival in breast cancer
por: Sjöberg, Elin, et al.
Publicado: (2016) -
Ectopic expression of the chemokine CXCL17 in colon cancer cells
por: Ohlsson, Lina, et al.
Publicado: (2016) -
Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients
por: Hinnis, A R, et al.
Publicado: (2007) -
High mobility group protein B1 is a predictor of poor survival in ovarian cancer
por: Machado, Lee R., et al.
Publicado: (2017)